Get the Stockscreener App
4.78
1.81%
0.09
Achieve Life Sciences Inc stock is traded at $4.78, with a volume of 350.47K.
It is up +1.81% in the last 24 hours and up +1.17% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$4.69
Open:
$4.69
24h Volume:
350.47K
Relative Volume:
0.31
Market Cap:
$254.46M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-4.3063
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
+3.35%
1M Performance:
+1.17%
6M Performance:
+43.83%
1Y Performance:
+15.34%
1-Day Range:
$4.68
$4.86
1-Week Range:
$4.56
$4.97
52-Week Range:
$1.84
$5.78
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
4.78 | 249.67M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
451.61 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
736.54 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
884.84 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.69 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
195.79 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-25-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
View All
Achieve Life Sciences Inc Stock (ACHV) Latest News
Achieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Net current asset value per share of Achieve Life Sciences, Inc. – BER:SP4P - TradingView
Achieve Life Sciences Announced Granting of New Hire Inducement Awards - The Manila Times
Achieve Life Sciences (Nasdaq: ACHV) grants 250,000 stock options to new CLO - Stock Titan
Achieve Life Sciences (ACHV) Stock Analysis Report | Financials & Insights - Benzinga
Stonepine Capital Management LLC Takes Position in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Why Achieve Life Sciences Inc. (SP4P) stock gets analyst attentionTrade Ideas & Fast Moving Market Watchlists - Newser
How strong is Achieve Life Sciences Inc. (SP4P) stock earnings growthQuarterly Portfolio Summary & Smart Allocation Stock Tips - Newser
Can Achieve Life Sciences Inc. (SP4P) stock sustain institutional flows2025 Earnings Impact & Capital Protection Trading Alerts - Newser
What is the fair value estimate for Achieve Life Sciences Inc. (SP4P) stock in 2025 - Newser
Is Achieve Life Sciences Inc. (SP4P) stock a defensive play amid uncertaintyEarnings Beat & Risk Managed Investment Entry Signals - Newser
Why Achieve Life Sciences Inc. (SP4P) stock could outperform next yearMarket Movers & Real-Time Chart Breakout Alerts - Newser
Is Achieve Life Sciences Inc. stock a contrarian buy2025 Major Catalysts & Fast Exit and Entry Strategy Plans - Newser
Is Achieve Life Sciences Inc. (SP4P) stock a fit for income portfoliosJuly 2025 Earnings & Trade Opportunity Analysis - Newser
Can Achieve Life Sciences Inc. (SP4P) stock sustain breakout momentumJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Can Achieve Life Sciences Inc. (SP4P) stock retain market dominanceMarket Sentiment Summary & Daily Price Action Insights - Newser
Franklin Resources Inc. Acquires 2,000,079 Shares of Achieve Life Sciences, Inc. $ACHV - MarketBeat
Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the most - Yahoo Finance
EBIT per share of Achieve Life Sciences, Inc. – SWB:SP4P - TradingView
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Coverage Initiated at Citizens Jmp - MarketBeat
Quarterly Risk: Can Achieve Life Sciences Inc. stock continue upward trendMarket Sentiment Summary & Reliable Price Breakout Signals - BỘ NỘI VỤ
Citizens Initiates Coverage of Achieve Life Sciences (ACHV) with Market Outperform Recommendation - Nasdaq
Achieve Life Sciences (ACHV) Receives New 'Market Outperform' Ra - GuruFocus
FDA Accepts Achieve Life Sciences, Inc. (ACHV) NDA Application for Cytisinicline in Smoking Cessation - Finviz
Citizens initiates Achieve Life Sciences stock with Market Outperform rating By Investing.com - Investing.com Canada
13 Best Canadian Penny Stocks to Buy Right Now - Insider Monkey
Raymond James reiterates Strong Buy on Achieve Life Sciences stock By Investing.com - Investing.com Canada
Highbridge Capital Management LLC Acquires New Stake in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Why Achieve Life Sciences Inc. stock could outperform in 2025July 2025 Technicals & Verified Swing Trading Watchlists - newser.com
What earnings margins imply for Achieve Life Sciences Inc. (SP4P) stockEarnings Beat & Safe Entry Zone Identification - newser.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
Will Achieve Life Sciences Inc. (SP4P) stock justify high valuationRecession Risk & Accurate Buy Signal Notifications - newser.com
Can Achieve Life Sciences Inc. stock maintain growth trajectoryTrade Exit Summary & Risk Controlled Stock Alerts - newser.com
What dividend safety score for Achieve Life Sciences Inc. stockForecast Cut & Weekly Consistent Profit Watchlists - newser.com
Can Achieve Life Sciences Inc. stock withstand economic slowdownJuly 2025 Gainers & Weekly High Return Forecasts - newser.com
Is Achieve Life Sciences Inc. (SP4P) stock a momentum leaderWeekly Market Report & Capital Efficiency Focused Ideas - newser.com
Is Achieve Life Sciences Inc. stock a buy for dividend growthMarket Movers & Advanced Swing Trade Entry Plans - newser.com
Will Achieve Life Sciences Inc. stock return to pre crisis levels2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
Can Achieve Life Sciences Inc. stock deliver strong Q4 earningsEarnings Growth Report & Stepwise Swing Trade Plans - newser.com
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
1.61%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):